pMXs-IRES-Puro Retroviral Expression Vector

pMXs-IRES-Puro Retroviral Expression Vector
  • Cloning capacity = 5.4 kb

 

Frequently Asked Questions about packaging Retrovirus

General FAQs about Viral Gene Delivery

Email To BuyerPrint this PageCopy Link
Ordering

Please contact your distributor for pricing.

pMXs-IRES-Puro Retroviral Vector
Catalog Number
RTV-014
Size
10 µg
Detection
N/A
Manual/Data Sheet Download
SDS Download
Map Download
Sequence Download
Price
$530.00
Recent Product Citations
  1. Fukushima, Y.  et al. (2025). Functional and structural analysis of KK-LC-1-specific T cell receptors from patients with lung Cancer for immunotherapy. Cell Immunol. doi: 10.1016/j.cellimm.2025.105059.
  2. Tamamura, Y. et al. (2025). Notch signaling modulates Fgf23 expression through crosstalk with hypoxia and PTH pathways in osteogenic cells. Mol Cell Endocrinol. doi: 10.1016/j.mce.2025.112663.
  3. da Silva Almeida, A. et al. (2025). Building a potent TREM2 agonistic, biparatopic, common light chain antibody. MAbs. 17(1):2546554. doi: 10.1080/19420862.2025.2546554.
  4. Kuroda, M. et al. (2025). SARS-CoV-2 virus lacking the envelope and membrane open-reading frames as a vaccine platform. Nat Commun. 16(1):4453. doi: 10.1038/s41467-025-59533-4.
  5. Trsan, T. et al. (2024). The centrosomal protein FGFR1OP controls myosin function in murine intestinal epithelial cells. Dev Cell. doi: 10.1016/j.devcel.2024.06.001.
  6. Sugita, Y. et al. (2024). Candidate tumor-specific CD8+ T cell subsets identified in the malignant pleural effusion of advanced lung cancer patients by single-cell analysis. Oncoimmunology. 13(1):2371556. doi: 10.1080/2162402X.2024.2371556.
  7. Fuseya, Y. et al. (2024). Attenuation of HOIL-1L ligase activity promotes systemic autoimmune disorders by augmenting linear ubiquitin signaling. JCI Insight. 9(3):e171108. doi: 10.1172/jci.insight.171108.
  8. Motohashi, N. et al. (2023). Inherited myogenic abilities in muscle precursor cells defined by the mitochondrial complex I-encoding protein. Cell Death Dis. 14(10):689. doi: 10.1038/s41419-023-06192-2.
  9. Choe, J.H. et al. (2023). Li-Fraumeni Syndrome-Associated Dimer-Forming Mutant p53 Promotes Transactivation-Independent Mitochondrial Cell Death. Cancer Discov. 13(5):1250-1273. doi: 10.1158/2159-8290.CD-22-0882.
  10. Mizuike, A. et al. (2023). The C10orf76-PI4KB axis orchestrates CERT-mediated ceramide trafficking to the distal Golgi. J Cell Biol. 222(7):e202111069. doi: 10.1083/jcb.202111069.
  11. Jain, P. et al. (2022). Discovery and functional characterization of the oncogenicity and targetability of a novel NOTCH1-ROS1 gene fusion in pediatric angiosarcoma. Cold Spring Harb Mol Case Stud. 8(6):a006222. doi: 10.1101/mcs.a006222.
  12. Suzuki, Y. et al. (2022). Design and lyophilization of lipid nanoparticles for mRNA vaccine and its robust immune response in mice and nonhuman primates. Mol Ther Nucleic Acids. doi: 10.1016/j.omtn.2022.09.017.
  13. Masuta, Y. et al. (2022). Assessment of Fcγ receptor-dependent binding of influenza hemagglutinin vaccine-induced antibodies in a non-human primate model. iScience. 25(10):105085. doi: 10.1016/j.isci.2022.105085.
  14. Tsujita, K. et al. (2021). Homeostatic membrane tension constrains cancer cell dissemination by counteracting BAR protein assembly. Nat Commun. 12(1):5930. doi: 10.1038/s41467-021-26156-4.
  15. Maemura, T. et al. (2021). Antibody-Dependent Enhancement of SARS-CoV-2 Infection Is Mediated by the IgG Receptors FcγRIIA and FcγRIIIA but Does Not Contribute to Aberrant Cytokine Production by Macrophages. mBio. doi: 10.1128/mBio.01987-21.
  16. Legscha, K.J. et al. (2021). Δ133p53α enhances metabolic and cellular fitness of TCR-engineered T cells and promotes superior antitumor immunity. J Immunother Cancer. 9(6):e001846. doi: 10.1136/jitc-2020-001846.
  17. Yogosawa, S. et al. (2021). Carbonic anhydrase 13 suppresses bone metastasis in breast cancer. Cancer Treat Res Commun. doi: 10.1016/j.ctarc.2021.100332.
  18. Kuroda, M. et al. (2020). HER2-mediated enhancement of Ebola virus entry. PLoS Pathog. 16(10):e1008900. doi: 10.1371/journal.ppat.1008900.
  19. Kuroda, M. et al. (2020). Identification of interferon-stimulated genes that attenuate Ebola virus infection. Nat Commun. 11(1):2953. doi: 10.1038/s41467-020-16768-7.
  20. Nakashima, K. et al. (2020). Identification of aberrantly expressed long non‐coding RNAs in ovarian high‐grade serous carcinoma cells. Reprod Med Biol. doi: 10.1002/rmb2.12330.
  21. Murase, M. et al. (2018). Intravesicular Acidification Regulates Lipopolysaccharide Inflammation and Tolerance through TLR4 Trafficking. J Immunol. 200(8):2798-2808. doi: 10.4049/jimmunol.1701390.
  22. Li, Q. et al. (2018). A robust split-luciferase-based cell fusion screening for discovering myogenesis-promoting molecules. Analyst. 143(14):3472-3480. doi: 10.1039/c8an00285a.
  23. Liu, Y. et al. (2018). Identification of a Constitutively Active Mutant Mouse IRAK2 by Retroviral Expression Screening. Mol Biotechnol. 60(4):245-250. doi: 10.1007/s12033-018-0064-9.
  24. Avbelj, M. et al. (2018). The role of N-terminal segment and membrane association in MyD88-mediated signaling. Biochem Biophys Res Commun. 495(1):878-883. doi: 10.1016/j.bbrc.2017.11.099.
  25. Honda, M. et al. (2017). A novel near-infrared fluorescent protein, iRFP720, facilitates transcriptional profiling of prostate cancer bone metastasis in mice. Anticancer Res. 37(6):3009-3013.
  26. Tamamura, Y. et al. (2017). Irx3 and Bmp2 Regulate Mouse Mesenchymal Cell Chondrogenic Differentiation in Both a Sox9-Dependent and -Independent Manner. J. Cell. Physiol. doi: 10.1002/jcp.25776.
  27. Takizawa, F. et al. (2016). Novel teleost CD4-bearing cell populations provide insights into the evolutionary origins and primordial roles of CD4+ lymphocytes and CD4+ macrophages. J Immunol. doi:10.4049/​jimmunol.1600222.
  28. Jiang, S. et al. (2016). TLR10 is a negative regulator of both MyD88-dependent and-independent TLR signaling. J Immunol. doi:10.4049/jimmunol.1502599.
  29. Maxson, J. E. et al. (2015). Identification and characterization of tyrosine kinase nonreceptor 2 mutations in leukemia through integration of kinase inhibitor screening and genomic analysis. Cancer Res.doi:10.1158/0008-5472.
  30. Agarwal, A. et al. (2015). Functional RNAi screen targeting cytokine and growth factor receptors reveals oncorequisite role for interleukin-2 gamma receptor in JAK3-mutation-positive leukemia. Oncogene. 34:2991-2999.